Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nutritional bioscience firm Nutrition 21 has announced that Paul Intlekofer has resigned as CEO and as a director of the company. Gerard Butler and Michael Fink have been elected to serve as interim Co-CEOs.
Subscribe to our email newsletter
Both Mr Butler and Mr Fink were executives at Prestige Brands Holdings. They previously worked for Block Drug Company. They have extensive experience in the consumer and nutraceutical industry.
John Gutfreund, Nutrition 21’s chairman of the board, said: “We thank Paul for the many years of service that he has given to the company, and appreciate his desire to work in the vicinity of his home in Baltimore, Maryland. He will serve as a consultant to the company.”